Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-21-000082
Filing Date
2021-07-02
Accepted
2021-07-02 11:56:32
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162524137724591.html 4  
1 FORM 4 wf-form4_162524137724591.xml 4 3845
  Complete submission text file 0001457612-21-000082.txt   5297
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2000 BROADWAY PENTHOUSE 2B NEW YORK NY 10023
Business Address
Siber George (Reporting) CIK: 0001594631 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 211068650